Attachment F -- Oral meds for Type 2 diabetes clinician guide _ feedback survey for policymakers _ administrators

Attachment F -- Oral meds for Type 2 diabetes clinician guide _ feedback survey for policymakers _ administrators.doc

Eisenberg Center Voluntary Customer Survey Generic Clearance for the AHRQ

Attachment F -- Oral meds for Type 2 diabetes clinician guide _ feedback survey for policymakers _ administrators

OMB: 0935-0128

Document [doc]
Download: doc | pdf

Form Approved
OMB No. 0935-0128
Exp. Date XX/XX/20XX

Thank you for taking the time to tell us what you think about the Comparing Oral Medications for Adults with Type 2 Diabetes clinician summary guide. The information you provide will help us to improve current and future guides. You may choose not to answer any question, and your responses are completely anonymous. No information that could be used to identify you will be collected. The average time required to complete this survey is 5 minutes.

0. Please choose ONE statement that best describes you:

 

I am a health care professional who provides care to people with Type 2 diabetes


 X

I am a health care administrator or policymaker


 

I have Type 2 diabetes


 

I am the caregiver, family member or friend of someone with Type 2 diabetes


 

Other ---> Please describe yourself


1. How useful to you was the clinical bottom line section?

 

Very useful


 

Somewhat useful


 

Not very useful ---> Why not?


2. How useful to you was the confidence scale?

 

Very useful


 

Somewhat useful


 

Not very useful ---> Why not?


3. How useful was the cost information?

 

Very useful


 

Somewhat useful


 

Not very useful ---> Why not?


4. Did you learn anything new from the guide?

 

Yes, a lot


 

Yes, some


 

No




Public reporting burden for this collection of information is estimated to average 5 minutes per response, the estimated time required to complete the survey. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to: AHRQ Reports Clearance Officer Attention: PRA, Paperwork Reduction Project (0935-0128) AHRQ, 540 Gaither Road, Room #5036, Rockville, MD 20850.







5. Did you disagree with any of the information in the guide?

 

No


 

Yes ---> Please describe


6. Do you anticipate that you would use the information in this guide to: (please answer all items)

 

Inform/educate clinicians who treat people with Type 2 diabetes?

Yes

No

Not Applicable

Inform/educate patients who have Type 2 diabetes?

Yes

No

Not Applicable

Inform decisions about formularies or reimbursement?

Yes

No

Not Applicable

Influence clinical guidelines?

Yes

No

Not Applicable



7. Are there any other uses you would have for this guide?

 

No


 

Yes ---> Please describe


8. Would you recommend this clinician/policymaker guide to others?

 

Yes, definitely


 

Not sure ---> Why not?


 

No ---> Why not?


9. Would you like to give us any other comments or thoughts about the guide?

 



10. How did you find this guide?

 

Internet search


 

I received an e-mail notification from AHRQ's Effective Health Care Program


 

Link from another website ---> Which website?


 

Link from companion consumer's guide


 

Colleague


 

Professional organization email, newsletter, journal ---> Please describe


 

Other ---> Please describe


11. For what type of organization do you work?

 

University or other educational institution


 

Federal agency


 

State agency


 

County or city agency


 

HMO


 

Insurance provider


 

Pharmaceutical industry


 

Consumer advocacy organization


 

Professional advocacy organization


 

Other ---> Please describe


12. Are you:

 

Male


 

Female


13. What is your age?

 

Under 30


 

30-44


 

45-59


 

60 or older




File Typeapplication/msword
Authorsandra joos
Last Modified Bywcarroll
File Modified2009-07-01
File Created2008-12-04

© 2024 OMB.report | Privacy Policy